Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$72.75BHealthcare Market cap, Sector
Vir Biotechnology
VIR$1.71BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 VIR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsVIR
84B
F20
87A
F37
92A
F31
66C
F3
75B
F2
91A
F38
95A
F38
Side-by-side metrics
| Metric | JSLL.NS | VIR |
|---|---|---|
| Market cap | Winner: $72.75B | $1.71B |
| P/E (TTM) | 33.3x | - Winner |
| EV/EBIT | 24.1x | - Winner |
| ROIC (TTM) | Winner: 39.15% | -48.49% |
| Gross margin | 88.58% | 2.75% Winner |
| Net margin | Winner: 27.68% | -6.76% |
| Revenue CAGR 5y | Winner: 57.81% | -49.98% |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | 0.3x | 0.1x Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Revenue CAGR 5y57.81%vs -49.98%+186%
- ROIC (TTM)39.15%vs -48.49%+181%
- Net margin27.68%vs -6.76%+104%
- Market cap$72.75Bvs $1.71B+98%
VIR leads on
- EV/EBIT-vs 24.1x+111%
- P/E (TTM)-vs 33.3x+109%
- Gross margin2.75%vs 88.58%+68%
- Debt / Equity0.1xvs 0.3x+61%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.